These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10155606)

  • 1. Cephalosporin utilisation review and evaluation.
    Misan GM; Dollman C; Shaw DR; Burgess N
    Pharmacoeconomics; 1995 Aug; 8(2):100-22. PubMed ID: 10155606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of voluntary vs enforced compliance of third-generation cephalosporin use in a teaching hospital.
    Bamberger DM; Dahl SL
    Arch Intern Med; 1992 Mar; 152(3):554-7. PubMed ID: 1546918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins.
    Tice AD
    Drugs; 2000; 59 Suppl 3():29-35; discussion 47-9. PubMed ID: 10845411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL; Foster RH; Benfield P
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audit of third generation cephalosporin prescribing in a tertiary care hospital.
    LeMire M; Wing L; Gordon DL
    Aust N Z J Med; 1996 Jun; 26(3):386-90. PubMed ID: 8811213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symposium on antimicrobial therapy. IV. The cephalosporins.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jan; 86(1):7-12. PubMed ID: 8426246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.
    Adu A; Armour CL
    Drugs; 1995 Sep; 50(3):423-39. PubMed ID: 8521766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalosporin-probenecid drug interactions.
    Brown GR
    Clin Pharmacokinet; 1993 Apr; 24(4):289-300. PubMed ID: 8491057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy.
    Pinto Pereira LM; Phillips M; Ramlal H; Teemul K; Prabhakar P
    BMC Infect Dis; 2004 Dec; 4(1):59. PubMed ID: 15601475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audit of first generation cephalosporin usage.
    Shetty N; Shulman RI; Scott GM
    J Hosp Infect; 1999 Mar; 41(3):229-32. PubMed ID: 10204126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of antibiotic consumption and development of resistance by enterobacteria in a tertiary care hospital.
    Veličković-Radovanović R; Stefanović N; Damnjanović I; Kocić B; Antić S; Dinić M; Petrović J; Mitić R; Catić-Djordjević A
    J Clin Pharm Ther; 2015 Aug; 40(4):426-30. PubMed ID: 25953666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefepime--assessment of its need at a tertiary care center.
    Harbarth S; Pittet D; Gabriel V; Garbino J; Lew D
    J Clin Pharm Ther; 1998 Feb; 23(1):11-7. PubMed ID: 9756106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
    Pession A; Prete A; Paolucci G
    Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic antibiotics in abdominal hysterectomy.
    Tanos V; Rojansky N
    J Am Coll Surg; 1994 Nov; 179(5):593-600. PubMed ID: 7952465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of cephalosporin antibiotics in human healthcare.
    Bhopale GM
    Hindustan Antibiot Bull; 2009; 51(1-4):1-8. PubMed ID: 21268553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department.
    Borde JP; Kern WV; Hug M; Steib-Bauert M; de With K; Busch HJ; Kaier K
    Emerg Med J; 2015 Jul; 32(7):509-15. PubMed ID: 25261006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.